Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v7-EN
Language English English
Date Updated 2018-05-03 2018-05-03
Drug Identification Number 02239924 02239924
Brand name GLUCONORM 0.5MG GLUCONORM 0.5MG
Common or Proper name REPAGLINIDE REPAGLINIDE
Company Name NOVO NORDISK CANADA INC NOVO NORDISK CANADA INC
Ingredients REPAGLINIDE REPAGLINIDE
Strength(s) 0.5MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 x 100 tablets 1 x 100 tablets
ATC code A10BX A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2018-03-12 2018-03-12
Actual start date 2018-03-12 2018-03-12
Estimated end date 2018-05-14 2018-05-14
Actual end date 2018-05-02 2018-05-02
Shortage status Resolved Resolved
Company comments
Health Canada comments